An employee wearing personal protective equipment (PPE) works at the syringe filling line of Russian coronavirus vaccine EpiVacCorona, developed by the Vektor State Research Center of Virology and Biotechnology, at the production unit Vector-BiAlgam, in Novosibirsk, Russia.